Kyle Dennis of BiotechBreakouts.com picked Eiger BioPharmaceuticals (EIGR) as his Biotech Breakout of the Week, noting that the stock has a data release in October followed by two additional catalyst events scheduled for early in 2018. The additional catalysts help to shore up any possible downside, while the stock is trading well off its 52-week highs. Dennis — who has established a position in EIGR this week — said he would buy the stock below $8 per share, expecting a gain of at least $1 per share ahead of the October data, setting his stops at $7.50 per share.

Kyle Dennis is an events-based trader who runs Kyle Dennis’ Biotech Breakouts (biotechbreakouts.com). He had a small position in EIGR when he recorded this interview on Wednesday, and was planning to buy more under $8 per share, as he discussed. The Raging Bull podcast features experts from the site talking with Raging Bull editor Chuck Jaffe on his show, “Money Life with Chuck Jaffe.” You can learn more about Chuck’s daily hour of market and personal-finance chat at MoneyLifeShow.com; you can subscribe to the Raging Bull podcast via iTunes and other podcast providers.

Author: RagingBull

RagingBull is the foremost trading education website where traders of all skill and experience levels can learn to trade or to become a better trader. Students can learn from experienced stock and options traders, and be alerted to the real money trades these traders make. Become a better trader with RagingBull.com's courses and programs.

Learn More

Leave your comment

Related Articles: